Abstract
There is a category of large-scale neuromusculoskeletal injuries that result in long-term functional disabilities, and one such injury is volumetric muscle loss (VML) injury. In addition to the clinical outcomes related to long-term dysfunction, co-morbidities and reduced mobility and physical activity, this review addresses several underexplored physiological limitations of VML at both the whole-body level and within the injured muscle. Our objectives with this review are to provide: (1) critical understanding of the pathophysiological limitations related to VML injury; (2) evidence for emerging treatment options that target the VML-induced metabolic dysregulation; and (3) early functional data on metabolic treatments as a component of regenerative rehabilitation. We highlight new attempts to intervene in this unique pathophysiology, in addition to current unanswered questions for the field.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1718-1732 |
| Number of pages | 15 |
| Journal | Experimental Physiology |
| Volume | 111 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2026 |
Bibliographical note
Publisher Copyright:© 2025 The Author(s). Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
Keywords
- neuromusculoskeletal injury
- rehabilitation
- skeletal muscle injury
- β-adrenergic receptor agonist
Fingerprint
Dive into the research topics of 'When rehabilitation is not enough, how targeting metabolism can overcome the limited plasticity of skeletal muscle after traumatic injury'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS